首页 > 市场调查报告书 > 製药

癌症

南美洲和中美洲胶质瘤治疗市场预测至 2030 年 - 区域分析 - 按疾病、治疗类型、等级和最终用户

市场调查报告书

商品编码

1452590

南美洲和中美洲胶质瘤治疗市场预测至 2030 年 - 区域分析 - 按疾病、治疗类型、等级和最终用户

South & Central America Glioma Treatment Market Forecast to 2030 - Regional Analysis - by Disease, Treatment Type, Grade, and End User

出版日期: 2024年01月15日 | 出版商:

The Insight Partners | 英文 82 Pages | 订单完成后即时交付

价格

简介目录图表

南美洲和中美洲神经胶质瘤治疗市场预计将从2022年的1.1714亿美元增长到2030年的2.2774亿美元。预计2022年至2030年CAGR为8.7%。

新兴经济体增加的机会推动南美洲和中美洲神经胶质瘤治疗市场

巴西、俄罗斯、印度、中国和南非（金砖国家）是世界上成长最快的经济体之一。这些国家以及其他发展中经济体的医疗保健产业预计将在未来几年迅速扩张。预期成长归因于客户需求的变化、医疗保健服务意识的提高以及人口老化的持续增长。随着医疗保健产业的蓬勃发展，全球脑癌诊断市场可能在未来几年显着成长。此外，政府在医疗保健设施上的支出增加和消费者购买力有助于发展中国家医疗保健产业的成长。

在 COVID-19 疫情爆发前 20 年，美洲地区的医疗服务覆盖率有所改善，儘管进展缓慢。与 2000 年 65% 的人相比，2019 年 77% 的人拥有健康保险。政府卫生支出增加1.1个百分点，卫生人员数量增加。因此，该地区不断成长的医疗保健产业为神经胶质瘤治疗市场参与者创造了扩大业务的机会。

南美洲和中美洲神经胶质瘤治疗市场概述

南美洲和中美洲的神经胶质瘤治疗市场分为巴西、阿根廷以及南美洲和中美洲的其他地区。该地区的市场成长归因于脑癌发病率的上升和医疗保健系统发展的刺激。此外，拉丁美洲国家的大学正在与各种私人和上市公司合作，以支持与脑癌治疗相关的研究。人们对神经血管疾病的认识不断提高也有利于南美洲和中美洲的神经胶质瘤治疗市场。

根据世界资料.info，巴西是世界上面积和人口第五大的国家，并且正在经历最快的人口老化。根据 Globocan 2020 报告，脑癌是巴西最常见的死亡原因。 2020 年，巴西报告了 12,260 例新发脑癌病例，脑癌和中枢神经系统癌症导致 10,920 人死亡。此外，巴西所有年龄层的脑癌 5 年盛行率为每 10 万人约 15.17 例。阿根廷的癌症病例数正在稳定成长。根据世界卫生组织全球癌症观察站发布的Globocan报告，2020年阿根廷新诊断约1,831例脑癌病例，其中1,488人因脑癌死亡。阿根廷各年龄层脑癌的 5 年盛行率为每 10 万人口 11.62 例。

智利、哥伦比亚、秘鲁、古巴、委内瑞拉和玻利维亚是南美洲和中美洲神经胶质瘤治疗市场的主要贡献者。这些国家正在透过允许新的市场参与者进入市场来改善其医疗保健基础设施。此外，南美洲和中美洲其他国家正在投资并有兴趣改善其医疗保健研究活动并采用先进的脑癌疗法。

南美洲和中美洲胶质瘤治疗市场收入及 2030 年预测（百万美元）

南美洲和中美洲神经胶质瘤治疗市场细分

南美洲和中美洲神经胶质瘤治疗市场按疾病、治疗类型、等级、最终用户和国家细分。

根据疾病，南美洲和中美洲神经胶质瘤治疗市场分为星状细胞瘤、少突星状细胞瘤和少突胶质细胞瘤。 2022 年，星状细胞瘤细分市场在南美洲和中美洲神经胶质瘤治疗市场中占据最大份额。

依治疗类型，南美洲和中美洲胶质瘤治疗市场分为手术、化疗、放射治疗等。 2022 年，手术细分市场在南美洲和中美洲神经胶质瘤治疗市场中占最大份额。

根据级别，南美洲和中美洲神经胶质瘤治疗市场分为低级别和高级别。 2022 年，高层级细分市场在南美洲和中美洲神经胶质瘤治疗市场中占有更大份额。

根据最终用户，南美洲和中美洲神经胶质瘤治疗市场分为医院和诊所以及门诊手术中心。 2022 年，医院和诊所部门在南美洲和中美洲神经胶质瘤治疗市场中占有更大份额。

根据国家/地区，南美洲和中美洲神经胶质瘤治疗市场分为巴西、阿根廷以及南美洲和中美洲其他地区。 2022 年，巴西在南美洲和中美洲神经胶质瘤治疗市场占据主导地位。

Amgen Inc、Biocon Ltd、F. Hoffmann-La Roche Ltd、Merck & Co Inc、Pfizer Inc、Sun Pharmaceutical Industries Ltd 和 Teva Pharmaceutical Industries Ltd 是南美洲和中美洲神经胶质瘤治疗市场上的一些领先公司。

Brazil, Russia, India, China, and South Africa (BRICS) are among the fastest-growing economies in the world. The healthcare sectors in these countries, as well as other developing economies, are projected to expand rapidly in the coming years. The expected growth is ascribed to changes in customer demand, an increase in awareness about healthcare services, and a continuous rise in the aging population. The global brain cancer diagnostics market is likely to grow significantly in the coming years with the proliferation of the healthcare sector. Further, increased government spending on healthcare facilities and consumer purchasing power contribute to the growth of the healthcare sector in developing countries.

20 years before the COVID-19 epidemic, health service coverage in the Americas region improved, albeit slowly. Compared to 65% of people in 2000, 77% of people in 2019 had health insurance. Government spending on health expanded by 1.1 percentage points while the number of health personnel increased. Thus, the growing healthcare sector in the region creates opportunities for the glioma treatment market players to expand their business.

South & Central America Glioma Treatment Market Overview

The glioma treatment market in South & Central America is segmented into Brazil, Argentina, and the Rest of South & Central America. The market growth in this region is ascribed to the rising incidence of brain cancer and a spur in developments in healthcare systems. In addition, the universities in Latin American countries are collaborating with various private and public companies to support studies related to brain cancer treatment. The rising awareness about neurovascular disorders is also favoring the glioma treatment market in South & Central America.

Brazil is the fifth largest country in the world by area and population and is experiencing the fastest demographic aging as per the world data.info. As per the Globocan 2020 report, brain cancer is the most common cause of death in Brazil. 12,260 new cases of brain cancer were reported in Brazil in 2020, while brain and CNS cancers led to 10,920 deaths. Further, the 5-year prevalence rate of brain cancer in Brazil for all ages is ~15.17 per 100,000 population. The number of cancer cases in Argentina is increasing at a steady rate. According to the Globocan report published by the Global Cancer Observatory of the WHO, ~1,831 new cases of brain cancer were diagnosed in 2020, of which 1,488 deaths were reported due to brain cancer in Argentina. The 5-years prevalence rate of brain cancer for all age groups was found to be 11.62 per 100,000 population in Argentina.

Chile, Colombia, Peru, Cuba, Venezuela, and Bolivia are among other the key contributors to the glioma treatment market in South & Central America. These countries are improving their healthcare infrastructure by allowing new market players to enter into the marketplace. In addition, the countries in the Rest of South & Central America are investing and taking an interest in improving their healthcare research activities and adopting advanced therapies for brain cancer.

South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Glioma Treatment Market Segmentation

The South & Central America glioma treatment market is segmented into disease, treatment type, grade, end user, and country.

Based on disease, the South & Central America glioma treatment market is segmented into astrocytoma, oligoastrocytoma, and oligodendroglioma. The astrocytoma segment held the largest share of the South & Central America glioma treatment market in 2022.

Based on treatment type, the South & Central America glioma treatment market is segmented into surgery, chemotherapy, radiation therapy, and others. The surgery segment held the largest share of the South & Central America glioma treatment market in 2022.

Based on grade, the South & Central America glioma treatment market is segmented into low grade and high grade. The high grade segment held a larger share of the South & Central America glioma treatment market in 2022.

Based on end user, the South & Central America glioma treatment market is segmented into hospital & clinics and ambulatory surgical center. The hospital & clinics segment held a larger share of the South & Central America glioma treatment market in 2022.

Based on country, the South & Central America glioma treatment market is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America glioma treatment market in 2022.

Amgen Inc, Biocon Ltd, F. Hoffmann-La Roche Ltd, Merck & Co Inc, Pfizer Inc, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd are some of the leading companies operating in the South & Central America glioma treatment market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. South & Central America Glioma Treatment Market - Key Industry Dynamics

4.1 Market Drivers
- 4.1.1 High Incidence Rate of Brain Cancer in South America
- 4.1.2 Increase in Prevalence of High-Grade Glioma
4.2 Key Market Restraints
- 4.2.1 High Cost of Diagnosis
4.3 Key Market Opportunities
- 4.3.1 Advancements in Healthcare Sector in Emerging Economies
4.4 Future Trends
- 4.4.1 Surge in Drug Approvals for Glioma Treatment
4.5 Impact Analysis:

5. Glioma Treatment Market - South & Central America Market Analysis

5.1 South & Central America Glioma Treatment Market Revenue (US$ Mn), 2022 - 2030

6. South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 - by Disease

6.1 Overview
6.2 South & Central America Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
6.3 Astrocytoma
- 6.3.1 Overview
- 6.3.2 Astrocytoma: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Oligoastrocytoma
- 6.4.1 Overview
- 6.4.2 Oligoastrocytoma: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
6.5 Oligodendroglioma
- 6.5.1 Overview
- 6.5.2 Oligodendroglioma: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

7. South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 - by Treatment Type

7.1 Overview
7.2 South & Central America Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
7.3 Surgery
- 7.3.1 Overview
- 7.3.2 Surgery: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Chemotherapy
- 7.4.1 Overview
- 7.4.2 Chemotherapy: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Radiation Therapy
- 7.5.1 Overview
- 7.5.2 Radiation Therapy: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Others
- 7.6.1 Overview
- 7.6.2 Others: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 - by Grade

8.1 Overview
8.2 South & Central America Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
8.3 Low Grade
- 8.3.1 Overview
- 8.3.2 Low Grade: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.1 Grade I: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.3.2.2 Grade II: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
8.4 High Grade
- 8.4.1 Overview
- 8.4.2 High Grade: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.4.2.1 Grade III: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
  - 8.4.2.2 Grade IV: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 South & Central America Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Hospital & Clinics
- 9.3.1 Overview
- 9.3.2 Hospital & Clinics: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
- 9.4.1 Overview
- 9.4.2 Ambulatory Surgical Centers: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Glioma Treatment Market - Country Analysis

10.1 South & Central America Glioma Treatment Market, Revenue and Forecast to 2030
- 10.1.1 Overview
  - 10.1.1.1 South & Central America Glioma Treatment Market, by Country
  - 10.1.1.2 Brazil
    - 10.1.1.2.1 Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.2.2 Brazil: South & Central America Glioma Treatment Market, by Disease
    - 10.1.1.2.3 Brazil: South & Central America Glioma Treatment Market, by Treatment Type
    - 10.1.1.2.4 Brazil: South & Central America Glioma Treatment Market, by Grade
    - 10.1.1.2.4.1 Brazil: South & Central America Glioma Treatment Market, by Low Grade
    - 10.1.1.2.4.2 Brazil: South & Central America Glioma Treatment Market, by High Grade
    - 10.1.1.2.5 Brazil: South & Central America Glioma Treatment Market, by End User
  - 10.1.1.3 Argentina
    - 10.1.1.3.1 Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.3.2 Argentina: South & Central America Glioma Treatment Market, by Disease
    - 10.1.1.3.3 Argentina: South & Central America Glioma Treatment Market, by Treatment Type
    - 10.1.1.3.4 Argentina: South & Central America Glioma Treatment Market, by Grade
    - 10.1.1.3.4.1 Argentina: South & Central America Glioma Treatment Market, by Low Grade
    - 10.1.1.3.4.2 Argentina: South & Central America Glioma Treatment Market, by High Grade
    - 10.1.1.3.5 Argentina: South & Central America Glioma Treatment Market, by End User
  - 10.1.1.4 Rest of South & Central America
    - 10.1.1.4.1 Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
    - 10.1.1.4.2 Rest of South & Central America: South & Central America Glioma Treatment Market, by Disease
    - 10.1.1.4.3 Rest of South & Central America: South & Central America Glioma Treatment Market, by Treatment Type
    - 10.1.1.4.4 Rest of South & Central America: South & Central America Glioma Treatment Market, by Grade
    - 10.1.1.4.4.1 Rest of South & Central America: South & Central America Glioma Treatment Market, by Low Grade
    - 10.1.1.4.4.2 Rest of South & Central America: South & Central America Glioma Treatment Market, by High Grade
    - 10.1.1.4.5 Rest of South & Central America: South & Central America Glioma Treatment Market, by End User

11. Glioma Treatment Market Industry Landscape

11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 F. Hoffmann-La Roche Ltd
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Merck & Co Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Sun Pharmaceutical Industries Ltd
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Amgen Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Teva Pharmaceutical Industries Ltd
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Pfizer Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Biocon Ltd
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms

简介目录图表

List Of Tables

Table 1. South & Central America Glioma Treatment Market Segmentation
Table 2. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 3. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 4. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 5. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 6. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 7. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 8. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 9. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 10. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 11. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Low Grade
Table 12. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - High Grade
Table 13. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 14. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Disease
Table 15. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - Treatment Type
Table 16. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Grade
Table 17. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -Low Grade
Table 18. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) -High Grade
Table 19. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn) - End User
Table 20. Organic Developments Done By Companies
Table 21. Inorganic Developments Done By Companies
Table 22. Glossary of Terms, glioma treatment market

List Of Figures

Figure 1. South & Central America Glioma Treatment Market Segmentation, By Country
Figure 2. South & Central America Glioma Treatment Market - Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. South & Central America Glioma Treatment Market Revenue (US$ Mn), 2022 - 2030
Figure 5. South & Central America Glioma Treatment Market Revenue Share, by Disease 2022 & 2030 (%)
Figure 6. Astrocytoma: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Oligoastrocytoma: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Oligodendroglioma: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. South & Central America Glioma Treatment Market Revenue Share, by Treatment Type 2022 & 2030 (%)
Figure 10. Surgery: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Chemotherapy: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Radiation Therapy: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Others: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. South & Central America Glioma Treatment Market Revenue Share, by Grade 2022 & 2030 (%)
Figure 15. Low Grade: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Grade I: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Grade II: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. High Grade: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Grade III: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 20. Grade IV: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. South & Central America Glioma Treatment Market Revenue Share, by End User 2022 & 2030 (%)
Figure 22. Hospital & Clinics: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Ambulatory Surgical Centers: South & Central America Glioma Treatment Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. South & Central America Glioma Treatment Market, By Country, 2022 ($Mn)
Figure 25. South & Central America Glioma Treatment Market, By Key Countries, 2022 And 2030 (%)
Figure 26. Brazil: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 27. Argentina: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 28. Rest of South & Central America: South & Central America Glioma Treatment Market Revenue and Forecast to 2030 (US$ Mn)
Figure 29. Growth Strategies Done by the Companies in the Market, (%)